Gene expression studies performed by Kuehl and colleagues showed that multiple myeloma is associated explicitly with TRAF2 and TRAF3 gene mutations that promote activation of the NFκB system via an alternative pathway [14]. The gene discussed is NFKB1; the disease is plasma cell myeloma.